Physician

Joshua Agranat, MD

According to 2025 Medicare claims, Joshua Agranat, MD (NPI: 1639533888) practices ophthalmology in the Milwaukee-Waukesha, WI market, with the plurality of this provider's patient population coming from Waukesha, WI. This provider's primary affiliated billing organization is ADVANCED RETINA S.C. (NPI: 1063173128; TIN: 874176242) and primary practice location at 53018-2323.

Agranat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 478 traditional Medicare patients, billed 7,966 HCPCS/CPT codes, and received $608,702 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 212 prescription claims across 70 beneficiaries totaling $8,691 in drug costs, led by Brinzolamide (Brinzolamide). Open Payments data shows 5 records totaling $102. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $838 to $8,691. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$391K$781K2022 Medicare payment: $147,279 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $781,173 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $608,702 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20221801,353$147,279
20234368,217$781,173
20244787,966$608,702

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.2K$18K2016 Drug cost: $838 (USD; Tot_Drug_Cst)2017 Drug cost: $1,827 (USD; Tot_Drug_Cst)2018 Drug cost: $2,040 (USD; Tot_Drug_Cst)2019 Drug cost: $16,990 (USD; Tot_Drug_Cst)2020 Drug cost: $18,324 (USD; Tot_Drug_Cst)2021 Drug cost: $11,727 (USD; Tot_Drug_Cst)2022 Drug cost: $10,588 (USD; Tot_Drug_Cst)2023 Drug cost: $9,596 (USD; Tot_Drug_Cst)2024 Drug cost: $8,691 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R13$838
20173548$1,827
20183556$2,040
2019103274$16,990
202073226$18,324
202164183$11,727
202272170$10,588
202375260$9,596
202470212$8,691

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9393$124
67028Injection of drug into eye168441$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more121155$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more187216$67
92134Imaging of retina428768$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrinzolamideBrinzolamide18680$2,142
Prednisolone AcetatePrednisolone Acetate341,611$1,427
Ketorolac TromethamineKetorolac Tromethamine281,060$1,107
Timolol MaleateTimolol Maleate311,874$387
LatanoprostLatanoprost351,768$347

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$102Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua Agranat, MD?

Tedicare shows public-source Medicare data for Joshua Agranat, MD (NPI 1639533888), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Agranat, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Agranat, MD?

Joshua Agranat, MD is linked to ADVANCED RETINA S.C. (billing NPI 1063173128) in the available physician profile data.

Does Joshua Agranat, MD have Open Payments data?

Joshua Agranat, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.